Other Countries Outsideofthe United Statesand Europe — Product revenues, net
Vertex Pharmaceuticals Other Countries Outsideofthe United Statesand Europe — Product revenues, net remained flat by 0.0% to $248.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.6%, from $220.33M to $248.10M. Over 3 years (FY 2022 to FY 2025), Other Countries Outsideofthe United Statesand Europe — Product revenues, net shows an upward trend with a 23.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market penetration and growing demand in secondary international territories, while a decrease may signal competitive pressure or regulatory hurdles in those regions.
Detailed definition
This metric represents the net revenue generated from product sales in geographic regions outside of the primary domesti...
Peer comparison
Peers typically report this as 'Rest of World' revenue, which is often compared against total international revenue to gauge geographic diversification.
vrtx_segment_other_product_revenues_netHistorical Data
| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $525.90M | $719.80M | $881.30M | $992.40M |
| YoY Change | — | +36.9% | +22.4% | +12.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other countries outsideofthe united statesand europe — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported other countries outsideofthe united statesand europe — product revenues, net of $248.10M in Q4 2025.
- How has Vertex Pharmaceuticals's other countries outsideofthe united statesand europe — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's other countries outsideofthe united statesand europe — product revenues, net increased by 12.6% year-over-year, from $220.33M to $248.10M.
- What is the long-term trend for Vertex Pharmaceuticals's other countries outsideofthe united statesand europe — product revenues, net?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's other countries outsideofthe united statesand europe — product revenues, net has grown at a 23.6% compound annual growth rate (CAGR), from $525.90M to $992.40M.
- What does other countries outsideofthe united statesand europe — product revenues, net mean?
- Net revenue earned from product sales in international markets excluding the primary domestic and major European regions.